IVANOV, D. Safety and effectiveness of rheosorbilact detoxification therapy in stage 1–3 CKD. KIDNEYS, [S. l.], v. 10, n. 2, p. 65–69, 2021. DOI: 10.22141/2307-1257.10.2.2021.234321. Disponível em: https://www.kidneysjournal.com/index.php/journal/article/view/321. Acesso em: 16 mar. 2026.